| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Pseudomonas aeruginosa (ciprofloxacin-susceptible) |
1 |
2 |
0.25 － 4 |
Trovafloxacin (Trovan)  |
244 |
| Pseudomonas aeruginosa (ciprofloxacin-susceptible) |
1 |
4 |
0.25 － >4 |
Grepafloxacin (Raxar) |
244 |
| Pseudomonas aeruginosa (ciprofloxacin-susceptible) |
1 |
4 |
0.5 － 8 |
Besifloxacin (Besivance) |
1467 |
| Pseudomonas aeruginosa (ciprofloxacin-susceptible) |
2 |
2 |
0.5 － >8 |
Imipenem |
1467 |
| Pseudomonas aeruginosa (ciprofloxacin-susceptible) |
2 |
4 |
0.5 － 16 |
Moxifloxacin (BAY 12-8039, Avelox) |
1467 |
| Pseudomonas aeruginosa (ciprofloxacin-susceptible) |
2 |
8 |
0.5 － >16 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
1467 |
| Pseudomonas aeruginosa (ciprofloxacin-susceptible) |
>4 |
>4 |
0.5 － >4 |
Moxifloxacin (BAY 12-8039, Avelox) |
244 |
| Pseudomonas aeruginosa (ciprofloxacin-susceptible) |
>32 |
>32 |
4 － >32 |
Nalidixic acid (NegGam) |
244 |
| Pseudomonas aeruginosa (ciprofloxacin-susceptible) |
- |
2 |
0.25 － 4 |
Levofloxacin (Levaquin, Quixin) |
244 |
| Pseudomonas aeruginosa (ciprofloxacin-susceptible) |
- |
- |
0.5 － ? |
Tobramycin (Tobrex, Nebcin) |
774 |
| Pseudomonas aeruginosa (ciprofloxacin-susceptible) |
- |
- |
1.5 － ? |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
774 |
| Pseudomonas aeruginosa (ciprofloxacin-susceptible) |
- |
- |
2 － ? |
Polymyxin B (Aerospin) |
774 |
| Pseudomonas aeruginosa (ciprofloxacin-susceptible) |
- |
- |
3 － ? |
Amikacin (Amikin) |
774 |
| Pseudomonas aeruginosa (ciprofloxacin-susceptible) |
- |
- |
3 － ? |
Gentamicin (Gentamycin, Garamycin) |
774 |
| Pseudomonas aeruginosa (ciprofloxacin-susceptible) |
- |
- |
24 － ? |
Ticarcillin (Ticar) |
774 |
| Pseudomonas aeruginosa (clinical isolate) |
0.25 |
8 |
≤0.06 － >16 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
1133 |
| Pseudomonas aeruginosa (clinical isolate) |
0.5 |
8 |
≤0.03 － >32 |
Meropenem (Merrem) |
1133 |
| Pseudomonas aeruginosa (clinical isolate) |
1 |
16 |
≤0.06 － >32 |
Levofloxacin (Levaquin, Quixin) |
1133 |
| Pseudomonas aeruginosa (clinical isolate) |
2 |
2 |
≤0.06 － 8 |
Polymyxin E (Colistin) |
1133 |
| Pseudomonas aeruginosa (clinical isolate) |
2 |
8 |
≤0.06 － >16 |
Ceftazidime/NXL104 |
1133 |
| Pseudomonas aeruginosa (clinical isolate) |
2 |
16 |
≤0.5 － >32 |
Gentamicin (Gentamycin, Garamycin) |
1133 |
| Pseudomonas aeruginosa (clinical isolate) |
4 |
16 |
≤0.25 － >64 |
Cefepime (Maxipime) |
1133 |
| Pseudomonas aeruginosa (clinical isolate) |
4 |
32 |
≤0.25 － >32 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
1133 |
| Pseudomonas aeruginosa (clinical isolate) |
4 |
64 |
≤1 － >512 |
Zosyn |
1133 |
| Pseudomonas aeruginosa (clinical isolate) |
8 |
16 |
≤1 － >64 |
Amikacin (Amikin) |
1133 |
| Pseudomonas aeruginosa (clinical isolate) |
- |
- |
1.5 － ? |
Polymyxin B (free) |
929 |
| Pseudomonas aeruginosa (clinical isolate) |
- |
- |
>50 － ? |
Ornithodoros defensin A |
251 |
| Pseudomonas aeruginosa (COL-1) |
- |
- |
0.25 － ? |
Aztreonam (Azactam) |
657 |